| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09ec716d90c8adaa34351b97b6202988 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458 |
| filingDate |
2014-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd680a8861634107cd630b54f833879c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ae6a03b9144671b3cf13fc4773cc6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e0a4d3c37d4deb30518103d0b882e22 |
| publicationDate |
2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015083599-A |
| titleOfInvention |
Pharmaceutical composition for controlled release of methylphenidate |
| abstract |
Disclosed is a pharmacology for controlled release that can freely control the release pattern of methylphenidate contained in a core substance and can mask the bitter taste of methylphenidate for a certain period of time even when exposed to the oral cavity. Provisional composition. A core material containing methylphenidate; and a plurality of release controlling particles including a release controlling polymer coating layer formed on the core material, wherein the plurality of release controlling particles include: Based on the average thickness of the release controlling polymer coating layer, it is divided into two or more groups, and each particle group has the same polymer composition of the polymer coating layer, but the average coating thickness is A controlled release pharmaceutical composition characterized in that it is different. The pharmaceutical composition for controlled release can freely control the release pattern of methylphenidate contained in the core substance, and can be used as various forms of oral preparations including rapidly disintegrating tablets. It is. [Selection figure] None |
| priorityDate |
2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |